Effect of Ranolazine on Gastrointestinal Motor Function and Pain in Patients With IBS-D

NCT02239926 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Difficulty in enrolling subjects

Conditions

Diarrhea Predominant Irritable Bowel Syndrome

Interventions

DRUG: Ranolazine
DRUG: Placebo

Sponsor

Mayo Clinic